Stoke Therapeutics (STOK) Receivables - Other (2022 - 2025)
Stoke Therapeutics (STOK) has 4 years of Receivables - Other data on record, last reported at $1.6 million in Q3 2025.
- For Q3 2025, Receivables - Other rose 129.96% year-over-year to $1.6 million; the TTM value through Sep 2025 reached $1.6 million, up 129.96%, while the annual FY2024 figure was $700000.0, 993.75% up from the prior year.
- Receivables - Other reached $1.6 million in Q3 2025 per STOK's latest filing, down from $1.6 million in the prior quarter.
- Across five years, Receivables - Other topped out at $1.6 million in Q2 2025 and bottomed at $11000.0 in Q1 2024.
- Average Receivables - Other over 4 years is $527333.3, with a median of $395000.0 recorded in 2022.
- Peak YoY movement for Receivables - Other: crashed 97.76% in 2024, then surged 5409.09% in 2025.
- A 4-year view of Receivables - Other shows it stood at $588000.0 in 2022, then crashed by 89.12% to $64000.0 in 2023, then surged by 993.75% to $700000.0 in 2024, then surged by 127.0% to $1.6 million in 2025.
- Per Business Quant database, its latest 3 readings for Receivables - Other were $1.6 million in Q3 2025, $1.6 million in Q2 2025, and $606000.0 in Q1 2025.